Dupont Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-11,435
| Closed | -$508K | – | 1711 |
|
|
2022
Q2 | $508K | Hold |
11,435
| – | – | 0.02% | 680 |
|
|
2022
Q1 | $566K | Sell |
11,435
-4,020
| -26% | -$199K | 0.02% | 702 |
|
|
2021
Q4 | $787K | Sell |
15,455
-6,162
| -29% | -$314K | 0.03% | 627 |
|
|
2021
Q3 | $1.21M | Sell |
21,617
-3,056
| -12% | -$170K | 0.04% | 481 |
|
|
2021
Q2 | $1.06M | Buy |
+24,673
| New | +$1.06M | 0.02% | 555 |
|
|
2019
Q2 | – | Sell |
-18,131
| Closed | -$915K | – | 1280 |
|
|
2019
Q1 | $915K | Hold |
18,131
| – | – | 0.02% | 575 |
|
|
2018
Q4 | $730K | Buy |
18,131
+12,695
| +234% | +$511K | 0.02% | 621 |
|
|
2018
Q3 | $377K | Hold |
5,436
| – | – | 0.01% | 772 |
|
|
2018
Q2 | $411K | Hold |
5,436
| – | – | 0.01% | 748 |
|
|
2018
Q1 | $286K | Sell |
5,436
-9,699
| -64% | -$510K | 0.01% | 772 |
|
|
2017
Q4 | $809K | Buy |
+15,135
| New | +$809K | 0.02% | 562 |
|
|
2017
Q3 | – | Sell |
-8,465
| Closed | -$668K | – | 999 |
|
|
2017
Q2 | $668K | Buy |
8,465
+4,380
| +107% | +$346K | 0.01% | 613 |
|
|
2017
Q1 | $339K | Hold |
4,085
| – | – | 0.01% | 770 |
|
|
2016
Q4 | $324K | Buy |
+4,085
| New | +$324K | 0.01% | 762 |
|